New gram-negative enteropathogens: Fact or fancy?

Reviews and Research in Medical Microbiology

Volumn 17, Issue 1, 2006, Pages 27-37

  Janda, J Michael ^a,b   Abbott, Sharon L ^a  

^a Division of Communicable Disease Control   (United States)

^b Microbial Diseases Laboratory   (United States)

Author keywords

Aeromonadaceae; Bacteroidaceae; Campylobacteraceae; Diarrhea; Enterobacteriaceae; Enteropathogens; Gastroenteritis; Laribacter; Toxigenicity; Vibrionaceae; Virulence

Indexed keywords

AEROMONAS HYDROPHILA; AEROMONAS PUNCTATA; AEROMONAS VERONII; ARCOBACTER; BACTEROIDES FRAGILIS; BIOTYPE; CAMPYLOBACTER HYOINTESTINALIS; CAMPYLOBACTER LARI; CAMPYLOBACTER UPSALIENSIS; CITROBACTER FREUNDII; ENTEROPATHY; GASTROENTERITIS; GRAM NEGATIVE AEROBIC RODS AND COCCI; GRAM NEGATIVE ANAEROBIC BACTERIA; GRAM NEGATIVE ANAEROBIC COCCI; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HAFNIA ALVEI; HUMAN; KLEBSIELLA PNEUMONIAE; PRIORITY JOURNAL; PROVIDENCIA; REVIEW; SPECIES DIFFERENTIATION; VIBRIO FURNISSII; VIBRIO MIMICUS;

EID: 33749452839     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.revmedmi.0000237166.02265.1e     Document Type: Review

References (101)

1. Payment P, Riley MS. Resolving the Global Burden of Gastrointestinal Illness: a Call to Action. Washington, DC:American Academy of Microbiology; 2002; pp. 1-25.
2. Taylor DN, Connor BA, Shlim DR. Chronic diarrhea in the returned traveler. Med Clin N Am 1999; 83:1033-1052.
3. Guerrant RL, van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001; 32:331-350.
4. Svenungsson B, Lagergren Å, Ekwall E, Evengård B, Hedlund KO, Kärnell A, et al. Enteropathogens in adult patients with diarrhea and healthy control subjects: a 1-year prospective study in a Swedish clinic for infectious diseases. Clin Infect Dis 2000; 30:770-778.
5. DuPont HL. What's new in enteric infectious diseases at home and abroad. Curr Opin Infect Dis 2005; 18:407-412.
6. Gadewar S, Fasano A. Current concepts in the evaluation, diagnosis and management of acute infectious diarrhea. Curr Opin Pharmacol 2005; 5:559-565.
7. Aranda-Michel J, Giannella RA. Acute diarrhea: a practical review. Am J Med 1999; 106:670-676.
8. Falkow S. Molecular Koch's postulates applied to microbial pathogenicity. Rev Infect Dis 1988; 10:S274-S276.
9. Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, Lindblad L, et al. Human susceptibility and resistance to Norwalk virus infection. Nature Med 2003; 9:548-553.
10. Guarino A, Capano G, Malamisura B, Alessio M, Guandalini S, Rubino A. Production of Escherichia coli Sta-like heat-stable enterotoxin by Citrobacter freundii isolated from humans. J Clin Microbiol 1987; 25:110-114.
11. Guerrant RL, Dickens MD, Wenzel RP, Kapikian AZ. Toxigenic bacterial diarrhea: nursery outbreak involving multiple bacterial strains. J Pediatr 1976; 89:885-891.
12. Tschäpe H, Prager R, Streckel W, Fruth A, Tietze E, Böhme G. Verotoxigenic Citrobacter freundii associated with severe gastroenteritis and cases of haemolytic uremic syndrome in a nursery school: green butter as the infection source. Epidemiol Infect 1995; 114:441-450.
13. Jolivet-Gougeon A, Tamanai-Shacoori Z, Sauvager F, Cormier M. Production of Escherichia coli group I-like heat-labile enterotoxin by Enterobacteriaceae isolated from environmental waters. Microbios 1997; 90:209-218.
14. Oelschaeger TA, Guerry P, Kopecko DJ. Unusual microtubule-dependent endocytosis mechanisms triggered by Campylobacter jejuni and Citrobacter freundii. Proc Natl Acad Sci USA 1993; 90:6884-6888.
15. Guarino A, Giannella R, Thompson MR. Citrobacter freundii produces an 18-amino-acid heat-stable enterotoxin identical to the 18-amino-acid Escherichia coli heat-stable enterotoxin (ST Ia). Infect Immun 1989; 57:649-652.
16. Karasawa T, Ito H, Tsukamoto T, Yamasaki S, Kurazono H, Faruque SM, et al. Cloning and characterization of genes encoding homologues of the B subunit of cholera toxin and the Escherichia coli heat-labile enterotoxin from clinical isolates of Citrobacter freundii and E. coli. Infect Immun 2002; 70:7153-7155.
17. Schmidt H, Montag M, Bockemühl J, Heesemann J, Karch H. Shiga-like toxin II-related cytotoxins in Citrobacter freundii strains from humans and beef samples. Infect Immun 1993; 61:534-543.
18. Janda JM, Abbott SL. The genus Hafnia: from soup to nuts. Clin Microbiol Rev 2006; 19:12-18.
19. Albert MJ, Alam K, Islam M, Montanaro J, Rahman ASMH, Haider K, et al. Hafnia alvei, a probable cause of diarrhea in humans. Infect Immun 1991; 59:1507-1513.
20. Albert MJ, Faruque SM, Ansaruzzaman M, Islam MM, Haider K, Alam K, et al. Sharing of virulence-associated properties at the phenotypic and genetic levels between enteropathogenic Escherichia coli and Hafnia alvei. J Med Microbiol 1992; 37:310-314.
21. Günthard H, Pennekamp A. Clinical significance of extraintestinal Hafnia alvei isolates from 61 patients and review of the literature. Clin Infect Dis 1996; 22:1040-1045.
22. Ismaili A, Bourke B, de Azavedo JCS, Ratnam S, Karmali MA, Sherman PM. Heterogeneity in phenotypic and genotypic characteristics among strains of Hafnia alvei. J Clin Microbiol 1996; 34:2973-2979.
23. Ridell J, Siitonen A, Paulin L, Lindroos O, Korkeala H, Albert MJ. Characterization of Hafnia alvei by biochemical tests, random amplified polymorphic DNA PCR, and partial sequencing of 16S rRNA gene. J Clin Microbiol 1995; 33:2372-2376.
24. Janda JM, Abbott SL, Albert MJ. Prototypal diarrheagenic strains of Hafnia alvei are actually members of the genus Escherichia. J Clin Microbiol 1999; 37:2399-2401.
25. Huys G, Cnockaert M, Janda JM, Swings J. Escherichia albertii sp. nov., a diarrhoeagenic species isolated from stool specimens of Bangladeshi children. Int J Syst Evol Microbiol 2003; 53:807-810.
26. Hyma KE, Lacher DW, Nelson AM, Bumbaugh AC, Janda JM, Strockbine NA, et al. Evolutionary genetics of a new pathogenic Escherichia species: Escherichia albertii and related Shigella boydii strains. J Bacteriol 2005; 187:619-628.
27. Ratnam S, Butler RW, March S, Parsons S, Clarke P, Bell A, et al. Enterobacter hafniae-associated gastroenteritis - Newfoundland. Can Dis Weekly Rep 1979; 5:231-232.
28. Janda JM, Abbott SL, Khashe S, Probert W. Phenotypic and genotypic properties of the genus Hafnia. J Med Microbiol 2002; 51:575-580.
29. Crandall C, Abbott SL, Zhao YQ, Probert W, Janda JM. Isolation of toxigenic Hafnia alvei from a probable case of hemolytic uremic syndrome. Infection (in press).
30. Klipstein FA, Engert RF. Enterotoxigenic intestinal bacteria in tropical sprue. III. Preliminary characterization of Klebsiella pneumoniae enterotoxin. J Infect Dis 1975; 132:200-203.
31. Rennie RF, Anderson CM, Wensley BG, Albritton WL, Mahony DE. Klebsiella pneumoniae gastroenteritis masked by Clostridium perfringens. J Clin Microbiol 1990; 28:216-219.
32. Sabota JM, Hoppes WL, Ziegler JR, DuPont H, Mathewson J, Rutecki GW. A new variant of food poisoning: enteroinvasive Klebsiella pneumoniae and Escherichia coli sepsis from a contaminated hamburger. Am J Gastroenterol 1998; 93:118-119.
33. Guerin F, Le Bouguenec C, Gilquin J, Haddad F, Goldstein FW. Bloody diarrhea caused by Klebsiella pneumoniae: a new mechanism of bacterial virulence?. Clin Infect Dis 1998; 27:648-649.
34. Thi PLN, Yassibanda S, Aidara A, Le Bouguénec C, Germani Y. Enteropathogenic Klebsiella pneumoniae HIV-infected adults, Africa. Emerg Infect Dis 2003; 9:135-137.
35. Ananthan S, Raju S, Alavandi S. Enterotoxigenicity of Klebsiella pneumoniae associated with childhood gastroenteritis in Madras, India. Jpn J Infect Dis 1999; 52:16-17.
36. Guarino A, Guandalini S, Alessio M, Gentile F, Tarballo L, Capano G, et al. Characteristics and mechanism of action of a heat-stable enterotoxin produced by Klebsiella pneumoniae from infants with secretory diarrhea. Pediatr Res 1989; 25:514-518.
37. Haynes J, Hawkey PM. Providencia alcalifaciens and travellers' diarrhea. Br Med J 1989; 299:94-95.
38. Albert MJ, Alam K, Ansaruzzaman M, Islam MM, Rahman ASMH, Haider K, et al. Pathogenesis of Providencia alcalifaciens-induced diarrhea. Infect Immun 1992; 60:5017-5024.
39. Janda JM, Abbott SL, Woodward D, Khashe S. Invasion of HEp-2 and other eukaryotic cell lines by providenciae: further evidence supporting the role of Providencia alcalifaciens in bacterial gastroenteritis. Curr Microbiol 1998; 37:159-165.
40. Chilibek R, Jirous J, Beran J. Diarrhea outbreak among Czech Army Field Hospital personnel caused by Providencia alcalifaciens. J Travel Med 2002; 9:151-152.
41. Murata T, Iida T, Shiomi Y, Tagomori K, Akeda Y, Yanagihara I, et al. A large outbreak of foodborne infection attributed to Providencia alcalifaciens. J Infect Dis 2001; 184:1050-1055.
42. Möhr AJ, van der Lugt JJ, Josling D, Picard J, van der Merwe LL. Primary bacterial enteritis caused by Providencia alcalifaciens in three dogs. Vet Rec 2002; 150:52-53.
43. Magalhães V, Leal NC, Melo VM, Sobreira M, Magalhães M. Invasion of HeLa cells by Providencia alcalifaciens presumably is plasmid-encoded. Mem Inst Oswaldo Cruz 1996; 91:767-768.
44. Albert MJ, Ansaruzzaman M, Bhuiyan NA, Faruque ASG. Characteristics of invasion of HEp-2 cells by Providencia alcalifaciens. J Med Microbiol 1995; 42:186-190.
45. Rahman M, Monira S, Nahar S, Ansaruzzaman M, Alam K, Alam M, et al. TnphoA mutants of Providencia alcalifaciens with altered invasiveness of HEp-2 cells. J Med Microbiol 2002; 51:682-686.
46. Mathan MM, Mathan VI, Albert MJ. Electron microscopic study of the attachment and penetration of rabbit intestinal epithelium by Providencia alcalifaciens. J Pathol 1993; 171:67-71.
47. Chu YW, Wong CH, Tsang GKL, Kwok MSW, Wong RKO, Lo JYC, et al. Lack of association between presentation of diarrhoeal symptoms and faecal isolation of Aeromonas spp. amongst outpatients in Hong Kong. J Med Microbiol 2006; 55:349-351.
48. Janda JM, Abbott SL. Evolving concepts regarding the genus Aeromonas: An expanding panorama of species, disease presentations, and unanswered questions. Clin Infect Dis 1998. 27:332-244.
49. Chopra AK, Houston CW. Enterotoxins in Aeromonas - associated gastroenteritis. Microbes Infect 1999; 1:1129-1137.
50. Chopra AK, Peterson JW, Xu X-J, Coppenhaver DH, Houston CW. Molecular and biochemical characterization of a heat-labile cytotonic enterotoxin from Aeromonas hydrophila. Microb Pathog 1996; 21:357-377.
51. Janda J.M. Aeromonas and Plesiomonas. In: Molecular Medical Microbiology. Edited by Sussman M. London: Academic Press; 2001. pp. 1237-1270.
52. Reina J, Lopez A. Gastroenteritis caused by Aeromonas trota in a child. J Clin Pathol 1996; 49:173-175.
53. Singh DV, Sanyal SC. Enteropathogenicity of Aeromonas jandaei and A. trota. FEMS Immunol Med Microbiol 1997; 17:243-250.
54. Singh DV. A putative heat-labile enterotoxin expressed by strains of Aeromonas media. J Med Microbiol 2000; 49:685-689.
55. Shandera WX, Johnston JM, Davis BR, Blake PA. Disease from infection with Vibrio mimicus, a newly recognized Vibrio species. Ann Intern Med 1983; 99:169-171.
56. Campos E, Bolaños H, Acuña MT, Díaz G, Matamoros MC, Raventós H, et al. Vibrio mimicus diarrhea following ingestion of raw turtle eggs. Appl Environ Microbiol 1996; 62:1141-1144.
57. Mitra U, De SP, Bhattacharya MK, Dutta P, Rassaily R, Banerjee D, et al. Acute diarrhoea caused by Vibrio mimicus in Calcutta. J Assoc Physicians India 1993; 41:487-488.
58. Shi L, Miyoshi S, Hiura M, Tomochika K, Shimada T, Shinoda S. Detection of genes encoding cholera toxin (CT), zonula occludens toxin (ZOT), accessory cholera enterotoxin (ACE) and heat-stable enterotoxin (ST) in Vibrio mimicus clinical strains. Microbiol Immunol 1998; 42:823-828.
59. Boyd EF, Moyer KE, Shi L, Waldor MK. Infectious CTXΦ and the vibrio pathogenicity island prophage in Vibrio mimicus: evidence for recent horizontal transfer between V. mimicus and V. cholerae. Infect Immun 2000; 68:1507-1513.
60. Miyoshi S, Sasahara K, Akamatsu S, Rahman MM, Katsu T, Tomochika K, et al. Purification and characterization of a hemolysin produced by Vibrio mimicus. Infect Immun 1997; 65:1830-1835.
61. Yoshida H, Honda T, Miwatani T. Purification and characterization of a hemolysin of Vibrio mimicus that relates to the thermostable direct hemolysin of Vibrio parahaemolyticus. FEMS Microbiol Lett 1991; 84:249-254.
62. Uchimura M, Koiwai K, Tsuruoka Y, Tanaka H. High prevalence of thermostable direct hemolysin (TDH)-like toxin in Vibrio mimicus strains isolated from diarrhoeal patients. Epidemiol Infect 1993; 111:49-53.
63. Klontz KC, Desenclos JCA. Clinical and epidemiological features of sporadic infections with Vibrio fluvialis in Florida, USA. J Diarrhoeal Dis Res 1990; 8:24-26.
64. Dalsgaard A, Glerup P, Høybye LL, Paarup AM, Meza R, Bernal M, et al. Vibrio furnissii isolated from humans in Peru: a possible human pathogen? Epidemiol Infect 1997; 119:143-149.
65. Kothary MH, Lowman H, McCardell BA, Tall BD. Purification and characterization of enterotoxigenic El Tor-like hemolysin produced by Vibrio fluvialis. Infect Immun 2003; 71:3213-3230.
66. Magalhães V, Filho AC, Magalhães M, Gomes TT. Laboratory evaluation on pathogenic potentialities of Vibrio furnissii. Mem Inst Oswaldo Cruz 1993; 88:593-597.
67. Abbott SL, Janda JM. Severe gastroenteritis associated with Vibrio hollisae infection: report of two cases and review. Clin Infect Dis 1994; 18:310-312.
68. Kothary MH, Claverie EF, Miliotis MD, Madden JM, Richardson SH. Purification and characterization of a Chinese hamster ovary cell elongation factor of Vibrio hollisae. Infect Immun 1995; 63:2418-2423.
69. Nishibuchi M, Janda JM, Ezaki T. The thermostable direct hemolysin gene (tdh) of Vibrio hollisae is dissimilar in prevalence to and phylogenetically distant from the tdh genes of other vibrios: implications in the horizontal transfer of the tdh gene. Microbiol Immunol 1996; 40:59-65.
70. Miliotis MD, Tall BD, Gray RT. Adherence to and invasion of tissue culture cells by Vibrio hollisae. Infect Immun 1995; 63:4959-4963.
71. Patton CM, Shaffer N, Edmonds P, Barrett TJ, Lambert MA, Baker C, et al. Human disease associated with "Campylobacter upsaliensis" (catalase-negative or weakly positive Campylobacter species) in the United States. J Clin Microbiol 1989; 27:66-73.
72. Goossens H, Vlaes L, De Boeck M, Pot B, Kersters K, Levy J, et al. Is "Campylobacter upsaliensis" an unrecognized cause of human diarrhoea?. Lancet 1990; 335:584-586.
73. Jiminez GG, Heine RG, Ward PB, Robins-Browne RM. Campylobacter upsaliensis gastroenteritis in childhood. Pediatr Infect Dis J 1999; 18:988-992.
74. Lindblom GB, Sjögren E, Hansson-Westerberg J, Kaijser B. Campylobacter upsaliensis, C. sputorum, and C. concisus as common causes of diarrhoea in Swedish children. Scand J Infect Dis 1995; 27:187-188.
75. Labarca JA, Sturgeon J, Borenstein L, Salem N, Harvey SM, Lehnkering E, et al. Campylobacter upsaliensis: another pathogen for consideration in the United States. Clin Infect Dis 2002; 34:e59-e60.
76. Goossens H, Glesendorf BAJ, Vandamme P, Vlaes L, Van den Borre C, Koeken A, et al. Investigation of an outbreak of Campylobacter upsaliensis in day care centers in Brussels: analysis of relationships among isolates by phenotypic and genotypic typing methods. J Infect Dis 1995; 172:1298-1305.
77. Goossens H, Vlaes L, Butzler JP, Adnet A, Hanicq P, N'Jufom S, et al. Campylobacter upsaliensis enteritis associated with canine infections. Lancet 1991; 337:1486-1487.
78. Mooney A, Byrne C, Clyne M, Johnson-Henry K, Sherman P, Bourke B. Invasion of human intestinal cells by Campylobacter upsaliensis. Cell Microbiol 2003; 5:835-847.
79. Mooney A, Clyne M, Curran T, Doherty D, Kilmartin B, Bourke B. Campylobacter upsaliensis exerts a cytolethal distending toxin effect on HeLa and T lymphocytes. Microbiology 2001; 147:735-743.
80. Chiu CH, Kuo CY, Ou JT. Chronic diarrhea and bacteremia caused by Campylobacter lari in a neonate. Clin Infect Dis 1995; 21:700-701.
81. Broczyk A, Thompson S, Smith D, Lior H. Water-borne outbreak of Campylobacter laridis-associated gastroenteritis. Lancet 1987; 1:164-165.
82. Gorkiewicz G, Feierl G, Zechner R, Zechner EL. Transmission of Campylobacter hyointestinalis from a pig to a human. J Clin Microbiol 2002; 40:2601-2605.
83. Vandenberg O, Dediste A, Houf K, Ibekwem, Souayah H, Cadranel S, et al. Arcobacter species in humans. Emerg Infect Dis 2004; 10:1863-1867.
84. Prouzet-Mauléon, Labadi L, Bouges N, Ménard, Mégraud F. Arcobacter butzleri: underestimated enteropathogen. Emerg Infect Dis 2006; 12:307-309.
85. Myers L, Shoop DS, Stackhouse LL, Newman FS, Flaherty RJ, Letson GW, et al. Isolation of enterotoxigenic Bacteroides fragilis from humans with diarrhea. J Clin Microbiol 1987; 25:2330-2333.
86. Sears CL, Myers LL, Lazenby A, Van Tassell RL. Enterotoxigenic Bacteroides fragilis. Clin Infect Dis 1995; 20 (Suppl 2):S142-S148.
87. Sack RB, Albert MJ, Alam K, Neogi PKB, Akbar MS. Isolation of enterotoxigenic Bacteroides fragilis from Bangladeshi children with diarrhea: a controlled study. J Clin Microbiol 1994; 32:960-963.
88. Pantosti A, Menozzi MG, Frate A, Sanfilippo L, D'Ambrosio F, Malpeli M. Detection of enterotoxigenic Bacteroides fragilis and its toxin in stool samples from adults and children in Italy. Clin Infect Dis 1997; 24:12-16.
89. Balkovetz DF, Katz J. Bacterial invasion by a paracellular route: divide and conquer. Microbes Infect 2003; 5:613-619.
90. Kling JJ, Wright RL, Moncrief JS, Wilkins TD. Cloning and characterization of the gene for the metalloprotease enterotoxin of Bacteroides fragilis. FEMS Microbiol Lett 1997; 146:279-284.
91. Moncrief JS, Duncan AJ, Wright RL, Barroso LA, Wilkins TD. Molecular characterization of the fragilysin pathogenicity islet of enterotoxigenic Bacteroides fragilis. Infect Immun 1998; 66:1735-1739.
92. Donelli G, Fabbri A, Fiorentini C. Bacteroides fragilis enterotoxin induces cytoskeletal changes and surface blebbing in HT-29 cells. Infect Immun 1996; 64:113-119.
93. Wu S, Lim KC, Huang J, Saidi RF, Sears CL. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc Natl Acad Sci 1998; 95:14979-14984.
94. Yuen KY, Woo PCY, Teng JLL, Leung KW, Wong MKM, Lau SKP. Laribacter hongkongensis gen. nov., sp. nov., a novel gram-negative bacterium isolated from a cirrhotic patient with bacteremia and empyema. J Clin Microbiol 2001; 39:4227-4232.
95. Woo PCY, Kuhnert P, Burnens AP, Teng JLL, Lau SKP, Que TI, et al. Laribacter hongkongensis: a potential cause of infectious diarrhea. Diagn Microbiol Infect Dis 2003. 47:551-556.
96. Woo PCY, Lau SKP, Teng JLL, Yuen KY. Current status and future directions for Laribacter honkongensis, a novel bacterium associated with gastroenteritis and traveller's diarrhea. Curr Opin Infect Dis 2005; 18:413-419.
97. Woo PCY, Lau SKP, Teng JLL, Que TI, Yung RWH, Luk Wk, et al. Association of Laribacter hongkongensis in community-acquired gastroenteritis with travel and eating fish: a multicentre case-control study. Lancet 2004. 363:1941-1947.
98. Senior BW. Media for the detection and recognition of the enteropathogen Providencia alcalifaciens in faeces. J Med Microbiol 1997; 46:524-527.
99. Yoh M, Matsuyama J, Ohnishi M, Takagi K, Miyagi H, Mori K, et al. Importance of Providencia species as a major cause of travellers' diarrhea. J Med Microbiol 2005; 54:1077-1082.
100. Prindiville TP, Sheikh RA, Cohen SH, Tang YJ, Cantrell MC, Silva J Jr. Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. Emerg Infect Dis 2000; 6:171-174.
101. Wolk D, Mitchell S, Patel R. Principles of molecular microbiology testing methods. Infect Dis Clin N Am 2001; 15:1157-1204.